162 related articles for article (PubMed ID: 9833645)
1. [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
Neuropharmacology; 1998 Sep; 37(9):1147-58. PubMed ID: 9833645
[TBL] [Abstract][Full Text] [Related]
2. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
[TBL] [Abstract][Full Text] [Related]
3. Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.
López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
J Comp Neurol; 2001 Jan; 429(4):571-89. PubMed ID: 11135236
[TBL] [Abstract][Full Text] [Related]
4. [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand.
Johnson MP; Siegel BW; Carr AA
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):205-9. PubMed ID: 8857599
[TBL] [Abstract][Full Text] [Related]
5. Antagonist binding at 5-HT(2A) and 5-HT(2C) receptors in the rabbit: high correlation with the profile for the human receptors.
Aloyo VJ; Harvey JA
Eur J Pharmacol; 2000 Oct; 406(2):163-9. PubMed ID: 11020478
[TBL] [Abstract][Full Text] [Related]
6. Human striosomes are enriched in 5-HT2A receptors: autoradiographical visualization with [3H]MDL100,907,[125I](+/-)DOI and [3H]ketanserin.
López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
Eur J Neurosci; 1999 Oct; 11(10):3761-5. PubMed ID: 10564383
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
Noda-Saita K; Matsumoto M; Hidaka K; Hatanaka K; Ohmori J; Okada M; Yamaguchi T
Biochem Biophys Res Commun; 1999 Feb; 255(2):367-70. PubMed ID: 10049714
[TBL] [Abstract][Full Text] [Related]
8. [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography.
Lundkvist C; Halldin C; Ginovart N; Nyberg S; Swahn CG; Carr AA; Brunner F; Farde L
Life Sci; 1996; 58(10):PL 187-92. PubMed ID: 8602111
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.
Ito H; Nyberg S; Halldin C; Lundkvist C; Farde L
J Nucl Med; 1998 Jan; 39(1):208-14. PubMed ID: 9443763
[TBL] [Abstract][Full Text] [Related]
10. 5-HT receptors in mammalian brain: receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors.
Mengod G; Vilaró MT; Raurich A; López-Giménez JF; Cortés R; Palacios JM
Histochem J; 1996 Nov; 28(11):747-58. PubMed ID: 8968727
[TBL] [Abstract][Full Text] [Related]
11. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
Hoyer D; Pazos A; Probst A; Palacios JM
Brain Res; 1986 Jun; 376(1):97-107. PubMed ID: 2941113
[TBL] [Abstract][Full Text] [Related]
12. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.
Andrée B; Nyberg S; Ito H; Ginovart N; Brunner F; Jaquet F; Halldin C; Farde L
J Clin Psychopharmacol; 1998 Aug; 18(4):317-23. PubMed ID: 9690698
[TBL] [Abstract][Full Text] [Related]
15. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
Pranzatelli MR; Murthy JN; Pluchino RS
J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
[TBL] [Abstract][Full Text] [Related]
16. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
17. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
18. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
Hemedah M; Coupar IM; Mitchelson FJ
Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
[TBL] [Abstract][Full Text] [Related]
19. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors.
Pazos A; Hoyer D; Palacios JM
Eur J Pharmacol; 1984 Nov; 106(3):531-8. PubMed ID: 6519174
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
McKenna DJ; Peroutka SJ
J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
